The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study.
 
Dingwei Ye
No Relationships to Disclose
 
Shusuan Jiang
No Relationships to Disclose
 
Fang Yuan
No Relationships to Disclose
 
Fangjian Zhou
No Relationships to Disclose
 
Kui Jiang
No Relationships to Disclose
 
Xiaoping Zhang
No Relationships to Disclose
 
XingYa Li
No Relationships to Disclose
 
Lasika Seneviratne
No Relationships to Disclose
 
Guohua Yu
No Relationships to Disclose
 
Mingjun Zhang
No Relationships to Disclose
 
Shuang Zhang
No Relationships to Disclose
 
Mei Chen
Employment - Merck Sharp & Dohme
 
Gideon Blumenthal
Employment - Merck Sharp & Dohme
 
Omobolaji Akala
Employment - Merck Sharp & Dohme
 
Yaling Li
Employment - Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
 
Dian Jing
Employment - Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
 
Junyou Ge
Employment - Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
 
Yanxia Shi
No Relationships to Disclose